BaiXiaoAi AI Companion for Cancer Patient Follow-up

Starting soon

Conditions studied: Symptoms and Signs, Artificial Intelligence, Artificial Intelligence Mobile Application, Needs Assessment

In brief

This is a prospective, single-center, exploratory study designed to evaluate the accuracy, user engagement, and user experience of the BaiXiaoAi Companion AI. Upon signing the informed consent form and enrollment, a dedicated "Doctor-Nurse-Patient-AI" WeChat group will be established for each participant. Within the group, the BaiXiaoAi AI will provide timely responses based on patient communications and proactively push information regarding disease management and patient education.

Key facts

Study ID

NCT07396142

Run by

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

People needed

300

Starts

2026-01-14

Expected to finish

2027-11-30

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 years or older;
• Patients with a confirmed diagnosis of malignant neoplasms who are currently undergoing treatment or in follow-up, or their primary caregivers;
• Able to read and communicate in Chinese and independently use WeChat;
• Willing and able to provide informed consent.

You may not qualify if…

• Presence of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) or cognitive impairment (MMSE score < 24);
• Inability to use WeChat or communicate in Chinese;
• Considered by the investigators to be unsuitable for participation due to psychological or physical conditions.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.